Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles.

Proteins bound to nanoparticle surfaces are known to affect particle clearance by influencing immune cell uptake and distribution to the organs of the mononuclear phagocytic system. The composition of the protein corona has been described for several types of nanomaterials, but the role of the corona in nanoparticle biocompatibility is not well established. In this study we investigate the role of nanoparticle surface properties (PEGylation) and incubation times on the protein coronas of colloidal gold nanoparticles. While neither incubation time nor PEG molecular weight affected the specific proteins in the protein corona, the total amount of protein binding was governed by the molecular weight of PEG coating. Furthermore, the composition of the protein corona did not correlate with nanoparticle hematocompatibility. Specialized hematological tests should be used to deduce nanoparticle hematotoxicity. From the clinical editor: It is overall unclear how the protein corona associated with colloidal gold nanoparticles may influence hematotoxicity. This study warns that PEGylation itself may be insufficient, because composition of the protein corona does not directly correlate with nanoparticle hematocompatibility. The authors suggest that specialized hematological tests must be used to deduce nanoparticle hematotoxicity.

[1]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[2]  V. Puntes,et al.  Inorganic nanoparticle biomolecular corona: formation, evolution and biological impact. , 2012, Nanomedicine.

[3]  Rodney F. Minchin,et al.  Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. , 2012, ACS nano.

[4]  D. Hochstrasser,et al.  Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .

[5]  G. Nienhaus,et al.  Nanoparticle Interaction with Plasma Proteins as It Relates to Biodistribution , 2016 .

[6]  John C Bischof,et al.  Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. , 2009, Nanomedicine.

[7]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[8]  W. Peukert,et al.  Impact of the nanoparticle-protein corona on colloidal stability and protein structure. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[9]  Valery V Tuchin,et al.  Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery , 2009, Journal of biophotonics.

[10]  R. Müller,et al.  Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. , 2012, International journal of pharmaceutics.

[11]  Yi Lu,et al.  Colorimetric Biosensors Based on DNAzyme-Assembled Gold Nanoparticles , 2004, Journal of Fluorescence.

[12]  Rodney F. Minchin,et al.  Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses , 2012, Nanotoxicology.

[13]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[14]  R. Müller,et al.  Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  M. Michaelis,et al.  Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  Chad A Mirkin,et al.  Gold nanoparticle probes for the detection of nucleic acid targets. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[17]  Lawrence Tamarkin,et al.  Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery , 2004, Drug delivery.

[18]  Morteza Mahmoudi,et al.  Cell "vision": complementary factor of protein corona in nanotoxicology. , 2012, Nanoscale.

[19]  R. Müller,et al.  Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.

[20]  Scott E. McNeil,et al.  Handbook of Immunological Properties of Engineered Nanomaterials , 2016 .

[21]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[22]  Malcolm L. H. Green,et al.  Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.

[23]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[24]  T. Veenstra,et al.  Separation, detection and quantitation of peptides by liquid chromatography and capillary electrochromatography. , 2009, Journal of chromatography. A.

[25]  Malcolm L. H. Green,et al.  Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. , 2008, Journal of nanoscience and nanotechnology.

[26]  D. P. O'Neal,et al.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.

[27]  D. B. Zilversmit,et al.  Influence of exogenous proteins on blood clearance and tissue distribution of colloidal gold. , 1955, American Journal of Physiology.

[28]  L. Vroman,et al.  Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.

[29]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[30]  Andrzej S Pitek,et al.  Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.

[31]  J F Hainfeld,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.

[32]  Mitsuru Hashida,et al.  Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. , 2007, International journal of pharmaceutics.

[33]  D. Begley,et al.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[34]  R. Müller,et al.  Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.

[35]  Masahiko Nakamoto,et al.  Control of protein-binding kinetics on synthetic polymer nanoparticles by tuning flexibility and inducing conformation changes of polymer chains. , 2012, Journal of the American Chemical Society.

[36]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[37]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[38]  M. Olivo,et al.  Critical parameters in the pegylation of gold nanoshells for biomedical applications: An in vitro macrophage study , 2009, Journal of drug targeting.

[39]  Parag Aggarwal,et al.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.